N‐Demethylsinomenine Relieves Neuropathic Pain in Male Mice Mainly via Regulating α2‐Subtype GABAA Receptors
2025

N-Demethylsinomenine Relieves Neuropathic Pain in Male Mice

Sample size: 56 publication 10 minutes Evidence: high

Author Information

Author(s): Rong Weiwei, Qian Xunjia, Yin Yujian, Gu Yipeng, Su Weiyi, Li Jie-Jia, Xu Yue, Zhu Hongyan, Li Junxu, Zhu Qing

Primary Institution: Nantong University

Hypothesis

How does N-Demethylsinomenine exert analgesic actions?

Conclusion

The analgesic effects of N-Demethylsinomenine are primarily mediated by GABRA2 and partially by GABRA3, with inhibition of neuroinflammation contributing to its effects.

Supporting Evidence

  • N-Demethylsinomenine showed significant analgesic effects in both pain-evoked and pain-suppressed behavioral assays.
  • N-Demethylsinomenine treatment reversed the down-regulation of GABRA2 and up-regulation of inflammatory factors.
  • The analgesic effects were blocked by silencing GABRA2 and partially by silencing GABRA3.
  • N-Demethylsinomenine did not show peripheral anaphylaxis like sinomenine.

Takeaway

N-Demethylsinomenine helps reduce pain in mice by working on specific brain receptors and reducing inflammation.

Methodology

The study used behavioral assays and biochemical analyses to assess the effects of N-Demethylsinomenine on pain and receptor expression in mice.

Potential Biases

Potential bias due to the use of only male subjects and the specific pain models employed.

Limitations

The study only included male mice, which may limit the generalizability of the findings to females.

Participant Demographics

Male C57BL/6 mice, aged approximately 8 weeks.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1111/cns.70197

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication